BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:EPFL BioE Talks SERIES  "Biomaterial Strategies at the Neural Elec
 tronics-Tissue Interface"
DTSTART:20200928T160000
DTEND:20200928T170000
DTSTAMP:20260427T203417Z
UID:834e67a75a8a5fe59a55fd1c142f3d4b811b443ca1935a4bc9bb2956
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Xinyan Tracy Cui\, University of Pittsburgh\, Pittsburgh
 \, PA (USA)\nWEEKLY EPFL BIOE TALKS SERIES\n\n\nAbstract:\nMicroelectronic
  devices placed in the nervous system present tremendous potentials for ma
 pping neural circuits and treating neurological disorders. Currently\, the
  performance of these devices is sub-optimum due to electrode material lim
 itations and undesired host tissue responses. Quantitative histology and 2
 -photon imaging have revealed neuronal damage and degeneration\, inflammat
 ory gliosis\, blood brain barrier leakage and oxidative stress at the site
  of implants which may compromise the intended recording/stimulation/neuro
 chemical sensing function. We use several biomaterial strategies to minimi
 ze these responses in order to achieve seamless and stable device-tissue i
 nterface.  Conducting polymer based nanocomposites have been investigated
  as electrode coatings and facilitate the signal transduction/charge trans
 fer between the ionically conductive tissue and the electrical device.  N
 anostructuring is employed to improve the adhesion\, stability and charge 
 injection and drug delivery capability of the conducting polymers to meet 
 the material challenges at the neural interface. As we continue to improve
  our understanding of the implant induced tissue response\, bioactive appr
 oaches are being developed to modulate the cellular responses for seamless
  integration. Surface modification with bioactive molecules or anti-foulin
 g materials have been found to significantly improve neuronal health and i
 nhibit the inflammatory tissue response around the implants. Alternatively
 \, therapeutics that control inflammation\, neurodegeneration and oxidativ
 e stress can be delivered systemically or locally. These bioactive approac
 hes demonstrated significant benefit in neural recording quality and longe
 vity. The ultimate solution to a seamless device/tissue interface may be a
  combinatorial approach that takes advantage of multiple biomimetic strate
 gies discussed above and beyond.\n\nBio:\nDr. Tracy Cui is William Kepler 
 Whiteford Professor of Bioengineering at the University of Pittsburgh.  D
 r. Cui is the Director of the Neural Tissue/Electrode Interface and Neural
  Tissue Engineering Lab.  She is also the Neural Engineering Track Coordi
 nator for the Department of Bioengineering Graduate Committee. Prior to th
 is she was a Research Scientist at Unilever Research US in Edgewater\, New
  Jersey.\n\nDr. Cui earned her BE in Polymer Materials and Chemical Engine
 ering and her MS in Biophysics at Tsinghua University in Beijing\, China.
   She went on to earn her PhD in Macromolecular Science and Engineering a
 t the University of Michigan\, Ann Arbor\, Michigan.\n\nIn the Dr. Cui’s
  lab\, the primary research focus is on the interactions between neural ti
 ssue and smart biomaterials. This field of study is applied toward the bet
 ter understanding of the neural tissue/material interface and neural tissu
 e engineering.  Dr Cui’s research interests lie in neural engineering w
 ith special focuses on neural electrode-tissue interface\, neural tissue e
 ngineering\, central nervous system drug delivery\, and biosensors. \n\nF
 or her work\, Dr. Cui has won numerous awards\, most recently:\n \n\n	201
 7 Fellow of Royal Society of Chemistry in 2017\n	2016 Fellow of American I
 nstitute of Medical and Biological Engineering\n	2013 and 2014 Peking Univ
 ersity Engineering Globex Fellow\n	2013 Carnegie Science Emerging Female S
 cientist Award\n	2009\, 2011 and 2015 Pitt Innovator Award\n	2008 National
  Science Foundation Career Award\n	2005 Wallace Coulter Foundation Transla
 tional Early Career Award\n\n\nShe serves as a grant agency reviewer for t
 he National Institute of Health\, National Science Foundation\, National R
 esearch Agency of France\, Science Foundation of Ireland\, European Resear
 ch Council and the American Institute of Biological Sciences.  Dr. Cui ho
 lds 6 granted U.S. patents\, and she is a reviewer for many prestigious jo
 urnals\, such as Science\, Nature Communication\, ACS Nano Advanced Materi
 als\, Advanced Functional Materials\, Biomaterials\, Acta Biomaterialia\, 
 Biosensors and Bioelectronics\, Journal of Neural Engineering amongst othe
 rs.  Dr. Cui is on the editorial board of the Journal of Materials Chemis
 try B\, Journal of Neural Engineering\, Advanced NanoBiomedical Research a
 nd Current Opinion in Biomedical Engineering.\n\nDr. Cui has published 94 
 peer reviewed publications with H-index of 50. View a list of Dr. Cui’s 
 publications here\n\nhttps://scholar.google.com/citations?user=n3b7700AAAA
 J&hl=en\n\n\n\nZoom link (with registration) for attending remotely: https
 ://go.epfl.ch/EPFLBioETalks\n\n\nIMPORTANT NOTICE: due to restrictions res
 ulting from the ongoing Covid-19 situation\, this seminar can be followed 
 via Zoom web-streaming only\, following prior one-time registration throug
 h the link above.
LOCATION:via Zoom web-streaming only\, due to Covid-19 situation https://g
 o.epfl.ch/EPFLBioETalks
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
